The anti-MALL mAb 2G8 described in this study constitutes a unique tool for investigating the acquisition of the two alternative structures of MALL further, for analyzing its role in cancer, and for establishing pancreatic cancer prognosis. This evidence concerns the gene MALL and familial pancreatic carcinoma.